Previous Article | Next Article 
Infection and Immunity, September 2000, p. 5364-5376, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Immunopathology of Cerebral Malaria: Morphological Evidence of
Parasite Sequestration in Murine Brain Microvasculature
Jocelyn
Hearn,1
Neil
Rayment,1
David N.
Landon,2
David R.
Katz,1 and
J. Brian
de Souza1,*
Department of Immunology, Royal Free and
University College London Medical School, Windeyer Institute of
Medical Science, London W1P 6DB,1 and
Department of Neuropathology, Institute of Neurology,
London WC1N 3BG,2 United Kingdom
Received 13 March 2000/Returned for modification 12 May
2000/Accepted 10 June 2000
 |
ABSTRACT |
A murine model that closely resembles human cerebral malaria is
presented, in which characteristic features of parasite
sequestration and inflammation in the brain are clearly demonstrable.
"Young" (BALB/c × C57BL/6)F1 mice infected
with Plasmodium berghei (ANKA) developed typical
neurological symptoms 7 to 8 days later and then died, although their
parasitemias were below 20%. Older animals were less susceptible.
Immunohistopathology and ultrastructure demonstrated that neurological
symptoms were associated with sequestration of both parasitized
erythrocytes and leukocytes and with clogging and rupture of vessels in
both cerebral and cerebellar regions. Increases in tumor necrosis
factor alpha and CD54 expression were also present. Similar phenomena
were absent or substantially reduced in older infected but asymptomatic
animals. These findings suggest that this murine model is suitable both
for determining precise pathogenetic features of the cerebral form of
the disease and for evaluating circumventive interventions.
 |
INTRODUCTION |
Human cerebral malaria (CM) is a
serious neurological condition that can lead to coma and death. Its
principal feature is endothelial damage associated with the
sequestration of Plasmodium falciparum schizonts within the
microvasculature of the brain (24). However, studying CM in
humans is difficult because of the inability to correlate pathological
changes precisely with the clinical features. This is an important
prerequisite in the treatment of CM. Therefore, there is an obvious
need for experimental models that bear close similarity to human CM in
order to understand the precise mechanisms leading to coma and death
and for the development of therapeutic regimens. The phenomenon has
been extensively studied in experimental animals in order to find a
system that closely resembles CM in humans. Primate models,
particularly that of Plasmodium coatneyi infections in
rhesus monkeys (21), have given encouraging results but are
limited by practical and financial constraints. Murine models are more
suitable for experimental studies, but thus far it has always been
suggested that the findings do not resemble those seen during human CM
exactly. In both human and mouse, tumor necrosis factor alpha
(TNF)-induced upregulation of endothelial adhesion molecules has been
invoked as a factor in pathology involving the sequestration of cells
within the microvasculature of the brain and other major organs of the
body (15, 16). However, other studies have suggested that
there are differences between the two species, with a preference for
leukocyte sequestration in the mouse (14) rather than for
parasitized red blood cell sequestration, as seen in humans
(1).
In our previous studies on the role of cytokines during various
blood-stage malaria infections (12), we observed that
Plasmodium berghei ANKA infections in "young" 8-week-old
(BALB/c × C57BL/6)F1 mice frequently resulted in
neurological symptoms and early death (de Souza et al., unpublished
observations). These characteristic CM-associated symptoms were
less common in "older" (15 to 20 weeks) animals. These observations
have now been extended further and show that this model of murine
malaria does indeed bear a strong resemblance to human CM, including
the characteristic feature of parasite sequestration within the
microvasculature of the brain. Furthermore, the associated
immunopathological changes (e.g., rupture of blood vessels,
hemorrhage, and edema) add further evidence to suggest that
the pathogenesis of CM is not merely due to mechanical microvascular obstruction.
 |
MATERIALS AND METHODS |
Mice.
(BALB/c × C57BL/6)F1 mice were bred
at Biological Services, Royal Free and University College London
Medical School, from parental stocks obtained from the National
Institute for Medical Research, Mill Hill, London, United Kingdom. Mice
of both sexes were used at various ages between 8 and 20 weeks.
Parasite infection and follow-up.
P. berghei ANKA
parasites (from N. Wedderburn, Royal College of Surgeons, London,
United Kingdom) from liquid nitrogen stocks were subjected to at least
one in vivo passage prior to use in experimental infection. Mice of
different ages were infected intravenously (i.v.) with 104
parasitized red blood cells. Parasitemias were estimated on
Giemsa-stained blood films from day 3 onwards, and the animals' states
of health were closely monitored for neurological symptoms.
Production of P. berghei-specific antiserum for
immunohistochemistry.
Fifteen mice 8 to 10 weeks old were
vaccinated subcutaneously twice with 25 µg of P. berghei
semipurified antigen plus Provax (kindly provided by IDEC
Pharmaceuticals) as adjuvant 2 weeks apart, as described previously for
Plasmodium yoelii antigens (11). Three weeks
later, these animals and five unvaccinated controls were challenged
i.v. with 104 parasitized red blood cells, and their
parasitemias were monitored from day 5 onwards. Parasitemias of both
vaccinated and unvaccinated groups were patent on day 5. Four control
mice died on day 9, and one died on day 20. While 9 of 15 of the
vaccinated group failed to control their infection and died (3 on day
10 and 6 on day 17), 6 animals resolved their parasitemia and recovered on day 21. These animals were bled 3 days later for immune serum, which
was absorbed with normal mouse liver and red blood cells, filtered
(0.45-µm pore size; Millipore), aliquoted, and stored at
20°C.
Brain sections for histology and immunohistopathology.
CM-positive (CM+) mice displaying neurological symptoms
were sacrificed, usually between days 6 and 8 after infection, and their brains were removed carefully, examined, and stored in liquid nitrogen prior to sectioning for immunohistopathological analysis. Uninfected normal control and CM-negative (CM
) mice were
sacrificed at the same time. Animals were killed by mild terminal
anesthesia to prevent accidental damage caused by cervical dislocation.
Routine frozen histological sections 7-µm thick were prepared on
glass slides, fixed in acetone, air dried, and stored for 1 to 2 days
at
20°C to enable tissue adherence to the slides.
(i) Detection of parasites.
Parasites were detected on brain
sections with either Giemsa stain or a specific anti-P.
berghei ANKA antibody. Sections for Giemsa stain were fixed in
methanol and treated identically as for blood films.
A modified indirect immunofluorescence technique similar to the slide
fluorescence assay described for determining antiparasite antibody
titers on schizont-coated slides (10) was adapted for confirming the presence of parasites in the brain. Sections were incubated at room temperature first in a 1:200 dilution of immune serum
for 1 h. After three washes in phosphate-buffered saline (PBS)-0.2% bovine serum albumin-0.5% Tween, sections were incubated in a 1:100 dilution of a fluorescein isothiocyanate (FITC)-labeled polyclonal rabbit anti-mouse immunoglobulin (Ig; Dako, Copenhagen, Denmark) containing Evan's blue for 45 min. After three washes, sections were mounted and examined under UV incident light microscopy. Brightly fluorescing parasites were observed against a red background (due to the Evan's blue), which enabled the identification of brain
tissue and other cells. Normal mouse serum or PBS was used as a control.
(ii) Detection of pathological markers.
The presence of two
pathological markers, ICAM-1/CD54 and TNF, was investigated using a
standard indirect immunocytochemical technique. Primary monoclonal rat
anti-mouse ICAM-1/CD54, 10 ng/ml (KAT-1 clone; Southern Biotechnology
Associates), or hamster anti-mouse TNF, 15 µg/ml (Pharmingen), were
used with a rabbit anti-rat IgG biotinylated secondary antibody, 1:100
(Dako). Binding was detected with a streptavidin-horseradish peroxidase
conjugate, 1:100 (Pharmingen), and 3,3-diaminobenzidine, 1 mg/ml
(Sigma), as a substrate. Nuclei were visualized with hematoxylin stain.
(iii) Ultrastructural studies.
For ultrastructural studies,
animals from both the uninfected control and CM+ groups
were sacrificed as above, but immediately after opening, the cranial
cavity of the brain was flooded with chilled 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.4). The whole brains were then fixed by
immersion in the same fixative solution at 4°C. The cerebra and
cerebella were cut into 1.5-mm coronal and sagittal slices, respectively, and then fixed for a further 2 h in the same
solution; subsequently, and after a brief wash in buffer, for
1 h in 1% aqueous osmium tetroxide. The slices were then
dehydrated through graded ethanol solutions and embedded in Agar
100 epoxy resin. Thin sections cut from these blocks were stained with
aqueous lead citrate and methanolic uranyl acetate and examined in a
Jeol 1200ex electron microscope at 80 kV.
Statistics.
Significance levels were determined by
Student's t test for unpaired observations.
 |
RESULTS |
Characterization of P. berghei infections in
(BALB/c × C57BL/6)F1 mice.
Animals that were
developing CM were usually identifiable as ill, as judged by coat
ruffling and general immobility 24 h prior to developing full CM
symptoms and death. After 24 h, the symptoms progressed rapidly
(within 2 to 3 h) in clearly defined stages, beginning with
partial paralysis, fitting and hyperventilation, coma, and death.
Parasitemias at this stage were between 10 and 20% (Fig.
1), with few schizonts detectable on
blood films. These diagnostic criteria were consistent with the
development of CM, always appearing 6 to 8 days after infection.
Age-matched CM
animals had similar parasitemias, but
significantly more schizonts were seen on their blood films. These
CM
animals do not display the above symptoms but usually
progress to severe malaria 7 to 10 days later, with hyperparasitemia,
dehydration weight loss, and death due to severe anemia, as judged by
grossly reduced red blood cell density on Giemsa-stained blood films.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 1.
Course of P. berghei ANKA infection in
(BALB/c × C57BL/6)F1 mice. Groups of mice of
different ages were injected i.v. with 104 parasitized
erythrocytes. Parasitemias from Giemsa-stained tail blood films were
monitored from day 3 onwards. Representative parasitemias ± standard error (SE) from groups of 18 to 30 mice from five separate
experiments are shown.
|
|
Neurological symptoms followed by death were more frequent among
younger animals (Table
1). Thus, 8- to
10-week-old mice
weighing 18 to 20 g were highly susceptible to
CM, with a mortality
rate of 98% after 6 to 8 days of infection,
although their parasitemias
were low. Mice aged 11 to 14 weeks and
weighing 25 to 30 g were
relatively resistant, with only 32%
dying between days 7 and 10.
Some of the older animals who did not
encounter early death appeared
to display CM reversal; they were ill on
day 6 but seemed to have
reversed their symptoms at 24 h and
survived. Mice with these
features are known to die later of severe
anemia and hyperparasitemia
but without CM (
25). Mice aged
15 or more weeks and weighing
in excess of 35 g were least
affected, with 17% succumbing to
CM. Some of these animals also
displayed CM reversal.
Gross examination of CM brain.
CM+ animals were
sacrificed at the fitting or coma stages described above. Examination
of the cranium revealed hemorrhaging under the meninges, along a
central area extending from the tip of the cerebral hemisphere down to
the cerebellum and medulla oblongata. The latter signs were absent in
brains of infected but CM
and normal uninfected animals.
Macroscopic signs of edema were obvious, as judged by increased volume
and meningeal tension in brains removed from CM+ animals
compared with normals, but were also seen in the infected CM
animals.
Immunohistopathology.
Sagittal sections from the midline
region of brains taken from CM+, CM
, and
control uninfected mice were stained and examined. Sections were
carefully scanned over the entire area, including the cerebrum, cerebellum, corpora, and ventricular system. Intact blood vessels with
well-defined endothelial lining were always seen on normal uninfected
and CM
brain sections (Fig.
2C to H). In CM+ brain, the
vessels with intact endothelia were more difficult to detect (Fig. 2A
and B, Fig. 3A to H), due to their
generally distended nature, with the lumen packed with adhering
parasites and leukocytes and with areas of rupture and hemorrhage.
Parasites were detected by Giemsa staining or by immunofluorescence
with a P. berghei-specific antiserum. Standard
immunohistochemistry was used to confirm the known presence of
ICAM-1/CD54 and TNF.

View larger version (99K):
[in this window]
[in a new window]
|
FIG. 2.
Evidence of parasite and leukocyte
sequestration in the microvasculature of the brain during experimental
murine CM. Representative immunohistopathology of sagittal sections of
the cerebrum taken from normal uninfected, CM , and
CM+ animals on the same day after infection. (A and B)
Giemsa stain analysis of longitudinal sections of vessels from a
CM+ animal taken at the coma stage, showing vascular
distension, parasites and leukocytes in the lumen and sequestered (B,
long arrow), endothelial damage (A, long arrow), and signs of edema (B,
short arrow). (C and D) Giemsa stain analysis of longitudinal sections
of vessels from a CM (C, no parasites visible) and an
uninfected normal (D) animal. Arrows show intact endothelium and no
vascular distension. (E and F) ICAM-1 staining of vessels from
CM (E) and normal (F) animals. Arrows indicate positive
staining within intact endothelia, and no visible parasites in the
CM sample (E). (G and H) TNF staining of vessels from
CM (G) and normal (H) animals. Short arrow shows weak
staining and few mononuclear cells in the CM sample (G);
long arrows show various negatively stained vessels in the normal brain
sample (H). All panels: magnification, ×40.
|
|

View larger version (95K):
[in this window]
[in a new window]
|
FIG. 3.
Evidence of parasite and leukocyte
sequestration in the microvasculature of the brain during experimental
murine CM. Representative immunohistopathology of sagittal sections of
the cerebrum taken from an animal sacrificed at the coma stage. (A)
Giemsa stain showing damaged endothelium with schizont (short arrow)
and mononuclear cell (long arrow) discharge into the cerebrum. (B)
High-power view of hemorrhage site in A showing schizonts (short
arrow). (C and D) Cross-section of a plugged blood vessel, near the
corpus callosum, showing sequestration of FITC-stained schizonts (short
arrow) within the endothelium. Lesion also includes mononuclear cells
with attached fluorescing parasites (long arrow). Arrowhead shows
cerebral edema. (E) Lack of parasite-specific staining on section
stained with control normal mouse serum. Only background fluorescence
visible. Arrowhead shows cerebral edema. (F) Transmitted-light view of
panel E, showing location of parasites, some attached to mononuclear
cells (short arrow). (G) Positive ICAM-1 staining of longitudinal
section of a blood vessel. Arrow indicates sequestration and vascular
plug containing monocytes and parasites. (H) Positive TNF staining of
transverse section of blood vessel, showing damaged endothelium,
sequestration of monocytes, and parasites. Arrow shows leakage of
parasites from damaged endothelium. Magnifications: A, C, E, F, G, and
H, ×40; B and D, ×100.
|
|
(i) Detection of parasites by Giemsa staining.
It was of
interest to document Giemsa analysis on brain sections, as this has not
been reported previously for murine CM. In general, parasites were not
seen in CM
brain sections, including those from animals
(from all age groups) that recovered from their CM symptoms, and there
was no evidence of vascular distension compared with normal uninfected
brain (Fig. 2C and D). However, phagocytic cells with engulfed malarial
pigment were visible in vessels of the ventricular system of
CM
animals (data not shown); CM+ brain
sections showed parasites and leukocytes within blood vessels (Fig. 2A
and B) and in hemorrhages detected under low-power microscopy (Fig.
3A). In general, petechial and large hemorrhages containing parasites
were always identifiable in distinctive turquoise-colored areas (Fig.
3A and B). Schizonts were clearly seen as typical "bunches of
grapes" at higher magnification (Fig. 3B), and they were similar in
structure to schizonts normally seen on Giemsa-stained blood films.
Unruptured blood vessels within CM+ brains were distended
and packed with leukocytes. Some contained engulfed parasites as well
as free parasitized erythrocytes in close contact with the endothelium
(Fig. 2A and B). Small nonnucleated fragments, probably platelets, were
also seen in plugged vessels, and fine granules possibly released by
platelets were present in aggregates with leukocytes and parasites
(data not shown). Sequestration was evident in both cerebral and
cerebellar vessels in CM+ sections.
(ii) Detection of parasites by immunofluorescence.
In addition
to Giemsa analysis, an indirect immunofluorescence assay using a
specific anti-P. berghei immune serum was used to detect
parasites in brain sections. Weak fluorescence was only seen on
isolated endothelial cells, not on parasites, on CM brain sections
treated with normal mouse serum (Fig. 3E and F) or PBS (data not
shown). Furthermore, the anti-P. berghei-specific antiserum did not react with vasculature of normal brain tissue, and besides weak
background fluorescence, parasites were not detectable in CM
brain sections (data not shown). The immune serum, of
antibody titer 1:16,384 when tested on schizont-coated slides, reacted strongly with parasites on CM+ brain sections when used at
a dilution of 1:512 to 1:1,024. Bright fluorescent sequestering and
nonsequestering forms of parasite were visible on a red (Evan's blue)
background within vascular endothelia of both the cerebrum (Fig. 3C and
D) and the cerebellum (data not shown). Additionally, rosette-like
structures were seen adhering to the endothelium or existing freely
within the vasculature, and this was evident by both transmitted light
(Fig. 3F) and fluorescence (Fig. 3C and D) microscopy. These rosettes
comprised parasitized red blood cells bound to monocytes. This
technique was more sensitive in identifying parasite sequestration
phenomena and hemorrhages than Giemsa staining. Thus, it is clear that
sequestration of parasites along with leukocytes does occur within the
vasculature of the brain during experimental CM in (BALB/c × C57BL/6)F1 mice. Similar studies of CM+ brains
from C57BL/6 mice did not reveal the above findings (de Souza et al., unpublished).
(iii) TNF and ICAM-1/CD54 expression during CM.
Upregulation
of mediators of pathology during CM has been reported previously in
both murine (19) and human (33) malaria. Hence,
it was important to document these phenomena in this model. Both
quantitative and qualitative analyses were carried out. The number of
positively stained vessels was estimated from six representative microscope fields (magnification, ×20) per section, from a total of at
least six sections per brain sample; brains from three different CM+, CM
, or normal uninfected animals were
analyzed. Data were pooled and expressed as the mean percentage ± standard deviation (SD) of positively stained vessels pertaining
to the total number of vessels per microscope field analyzed. With
respect to ICAM-1, in the postcapillary venules and in the
larger-caliber vessels from normal brain, the endothelium was weakly
positive in 44% ± 2.1% of the vessels examined but was otherwise
intact (Fig. 2F). Relatively weak staining was also seen in 87% ± 2.0% (P < 0.002 compared with normal brain) of
vessels in CM
sections, and there was no evidence of
endothelial damage (Fig. 2E). However, in CM+ brain
sections, strong ICAM-1 staining was seen in 98% ± 1.2% (P < 0.03 and P < 0.0001 compared
with CM
and normal brain, respectively) of capillaries
and postcapillary venules. The lumens of many of these were occluded
with sequestered and nonsequestered leukocytes and parasites, and there
were clear signs of endothelial damage (Fig. 3G).
Only 10% ± 0.5% of the vessels in normal brain sections were weakly
positive for endothelial TNF expression (Fig.
2H), representing
baseline levels of TNF production. Weakly positive staining was
also
seen in 12.5% ± 0.7% (
P < 0.007 compared with
normal brain)
of vessels in CM

sections, and there was no
evidence of endothelial damage (Fig.
2G). Strong positive staining for
TNF was detected on leukocytes
and parasites and on small granular
nonnucleated bodies which
were not parasites in 50% ± 4.3%
(
P < 0.0001 compared with CM

and normal
brain) of cerebral and cerebellar vessels displaying
endothelial damage
in CM
+ brain sections (Fig.
3H).
(iv) Ultrastructural studies.
The presence of parasitized
erythrocytes and monocytes in both cerebral and cerebellar blood
vessels was confirmed by electron microscopy. Here we show the fine
structure of the cerebellum from uninfected control and infected mice.
Similar changes were seen in the cerebrum (data not shown).
In normal control cerebella, the endothelial cells showed no evidence
of activation and the erythrocytes were not in contact
with the
endothelium (Fig.
4). There was some
evidence of anoxic
change attributable to the need to fix the brain by
surface application
in situ prior to its removal. In addition, there
were some dark
shrunken Purkinje cells and distended glial and neuronal
mitochondria,
but the tissue was generally well preserved, there were
no hemorrhages,
and there was little swelling of the perivascular
astrocytic endfeet.
Few red cells were visible within the parenchymal
capillaries.

View larger version (138K):
[in this window]
[in a new window]
|
FIG. 4.
Fine structure of a capillary in the granule cell layer
of the cerebellum from a control uninfected animal. Bar, 3 µm.
|
|
A number of consistent pathological features were seen within the
cerebella of infected CM
+ mice displaying early
neurological symptoms. Many penetrating
vessels and parenchymal
capillaries were congested with red cells,
some of which showed reduced
density indicative of partial lysis
and contained parasites (Fig.
5A). Some vessels
contained activated
monocytes with numerous protrusions along the cell
membrane and
increased cytoplasmic vacuolation (Fig.
5B). The
capillaries themselves
showed occasional free parasites (Fig.
5A), and
there was disruption
of the endothelial wall (Fig.
6B) and
proliferation of the luminal
aspect of the endothelial cells (Fig.
6C).
Residual plasma within
the capillaries generally showed an increased
electron density
with some evidence of flocculation (Fig.
6D and E),
and the perivascular
astrocytic endfeet were considerably swollen (Fig.
5A,
5B, and
6E). Hemorrhages into the surrounding tissue were present
around
both penetrating vessels and parenchymal capillaries, and these
also included partially lysed red cells containing parasites (Fig.
6F).


View larger version (344K):
[in this window]
[in a new window]
|
FIG. 5.
Fine structure of postcapillary venules from the brain
of a CM+ animal displaying neurological symptoms. (A)
Venule from the cerebellum occluded by erythrocytes, one partially
lysed and containing a parasite (PE). Bar, 3 µm. (B) Capillary from
the cerebellum occluded by erythrocytes, one containing parasites (PE),
and an activated monocyte (M) (note membrane protrusions and
cytoplasmic vacuolation). Bar, 3 µm.
|
|



View larger version (497K):
[in this window]
[in a new window]
|
FIG. 6.
Ultrastructural detail of microvascular changes in the
brain leading to endothelial damage and hemorrhage during murine CM.
(a) Capillary containing erythrocytes, one parasitized (PE), and with
one parasite (P) free within the lumen. Bar, 2 µm. (b) Capillary from
the cerebellar parenchyma largely occluded by a partially lysed
parasitized erythrocyte. Note the break in the endothelial cell lining
(arrow). Bar, 1 µm. (c) Capillary in the granule cell layer showing
extensive proliferation of the endothelial luminal surface. Bar, 2 µm. (d) Capillary from the cerebellar parenchyma occluded by a
monocyte (M) and erythrocytes, one containing a parasite (PE). Bar, 2 µm. (e) Cerebellar capillary largely occluded by erythrocytes, one
containing a parasite (PE). Bar, 2 µm. (f) Hemorrhage into the
cerebellar parenchyma, with parasites visible within three partially
lysed erythrocytes. Bar, 5 µm.
|
|
These appearances are interpreted to indicate the existence of
extensive hemostasis, with endothelial cell disruption or necrosis
leading to hemorrhage, escape of parasitized red cells into the
cerebellar parenchyma, and perivascular astrocytic edema with
some
evidence of endothelial cell
activation.
 |
DISCUSSION |
Several important observations have been made in these studies.
First, this is the first time that a murine CM model has been defined
in which parasitized erythrocytes appear in close contact with the
microvascular endothelium of the brain, resembling the pattern seen in
humans. Second, this model of P. berghei infection using an
F1 mouse derived from two strains which have different susceptibility patterns is characterized not only by an age-dependent susceptibility to CM but also by a reversal of CM symptoms, as can
occur in humans. Third, the high expression of TNF and ICAM-1 associated with microvascular lesions of CM+ brain, and the
associated vascular injury, leakage, and rupture, together with
sequestration, confirmed at the electron microscopic level, suggest
that our experimental model resembles human CM much more closely than
any previous models have done.
To date, experimental murine CM has been extensively studied in
resistant (BALB/c) versus susceptible (CBA, C57BL, and A/J) strains of
mice (9). We have shown that susceptible and resistant traits coexist in (BALB/c × C57BL/6)F1 mice, and we
have observed (data not shown) that reversal of symptoms occurs in some
older animals. The age-related susceptibility of these mice to CM
cannot be explained in immunological terms but requires further
investigation. Nevertheless, there are two interesting findings in this
strain of mouse. First, mortality due to CM is restricted to younger animals, which would represent a small fraction if the study were based
on equal numbers of animals of specified ages. Second, an interesting
feature of our model is the reversal of CM in older animals. Both of
these features are also found in human P. falciparum malaria
(26). In the one strain where resolution has been found before, DBA/2J, the underlying mechanism of CM resolution appears to be
related to a vastly reduced degree of monocyte accumulation in the
microvasculature of the major organs of the body, including the brain
(27).
Previous studies which examined the immunopathology of the brain during
murine CM have not shown convincing parasite sequestration (27,
31). Studies using retinal wholemounts instead of brain sections
substantiate the view of leukocyte sequestration, but parasites were
not seen in the sections (5). Other studies of parasite
levels in the brain are either indirect, as judged by mRNA levels
(18), or demonstrable apparently in the absence of
inflammation (discussed below) and hemorrhage, as seen during the
lethal P. yoelii 17XL infection (20). This lack
of clear-cut demonstration of parasite sequestration and associated
pathology has led to the negative views about murine models for
studying the immunopathology of human CM. Our immunofluorescence
observations, showing venules plugged with parasites, suggesting that
sequestration does occur in (BALB/c × C57BL/6)F1
mice, are therefore extremely important. These studies have been
further substantiated by ultrastructural analyses, which have confirmed
the occurrence of hemostasis and close contact between parasitized
erythrocytes, activated leukocytes, and the endothelium. Furthermore,
the ultrastructure also shows associated "activation" of
endothelium, implying some degree of endothelial injury.
Leukocytes were also present in CM brain lesions of our animals, and we
are currently investigating the precise phenotypic characteristics of
these cells. Inflammatory changes involving CD4+ T cells
(15) are thought to be a characteristic of murine models, but they have also been implicated in human CM (30), with
cytokine involvement (3, 22). In addition, there is
convincing evidence that links increases in macrophages and microglial
cells in human CM brain parenchyma with inflammation and granuloma
formation (8). Nonnucleated cells resembling platelets,
clumped together with leukocytes, were also detected in our CM lesions.
Platelets are thought to play a vital role in CM-related vascular
injury, where they appear to fuse with TNF-activated endothelium and
enhance the adhesion of leukocytes via LFA-1 interactions (16,
23). Work is currently in progress to clarify the precise role of
platelets in the immunopathology seen in our model (collaboration with
G. Grau).
Overproduction of inflammatory cytokines TNF, interleukin-1, and gamma
interferon upregulate a number of adhesion molecules, including
ICAM-1/CD54 (17), CD36, and thrombospondin (28) on vascular endothelia of the major organs of the body, including the
brain. These molecules are involved in the pathogenesis of both human
and experimental CM. High expression of TNF and ICAM-1 in our
CM+ brain sections was seen not just in vascular
endothelial cells but also on leukocytes and parasites in
CM+ lesions. This provides further supportive evidence that
both parasitized erythrocytes and leukocytes contribute to the
microvascular lesion during murine CM as well as in humans.
High expression of host adhesion molecules, in particular ICAM-1
(19, 28), on activated vascular endothelia enhances the binding of infected red blood cells. This occurs via receptors on the
parasitized red blood cell surface and leads to sequestration phenomena
that are typical of cerebral malaria (1). The receptor has
been identified on P. falciparum-infected erythrocytes as the large membrane protein PfEMP1 (29), and therefore it
should now also be possible to identify the receptor on P. berghei-infected erythrocytes in our murine model. In addition, it
has been suggested that rosette formation (32) (between
infected and uninfected erythrocytes) and cytoadherence of rosettes to
the endothelium via CD36 or CD31 (13) may be contributory
factors in human CM. However, rosette formation has not been
demonstrated in P. berghei-infected mice, and the phenomenon
was not clearly seen in this study. Some rosette-like structures seen
fluorescing in the CM+ sections may indicate early stages
of phagocytosis. Plugging of the microvasculature by the latter type of
structures may have contributed to the clinical symptoms of our
CM+ animals, since they were absent in cerebral vessels of
our CM
animals. However, this is undoubtedly not the only
event, since increased local production of TNF may be the likely cause
of parasitized erythrocyte sequestration in the microvasculature and
endothelial injury occurring at the same time with leakage of parasites
into the environment of the brain, contributing clinically to fitting and coma. These studies support the microvascular hypothesis of CM
(2, 30) rather than the nitric oxide theory (4,
7), but it is also possible that the role of nitric oxide itself
is mediated at the endothelial level. It has recently been suggested that sequestration, through localized hypoxia, might contribute to
endothelial injury by enhancing cytokine-induced inducible nitric oxide
synthase (6). Hence, the combination of sequestration and
plugging plus endothelial damage leads to rupture as a priming event
rather than infarction.
In conclusion, therefore, this study has shown that our murine CM model
of P. berghei ANKA infection in (BALB/c × C57BL/6)F1 mice has several features in common with human
CM and may be useful in future work unraveling the underlying features
of the disease. A detailed understanding of the association between
parasite sequestration, endothelial injury, vessel rupture, and
cerebral symptoms will greatly assist in the development of effective
chemotherapeutic interventions.
 |
ACKNOWLEDGMENTS |
This work was supported by the Sir Jules Thorn Charitable Trust,
the British Heart Foundation, and a UCL discretionary grant.
J. Hearn was supported by a grant from the foundation established
by the late Jean Shanks.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Immunology, Royal Free and University College London Medical School, Windeyer Institute of Medical Science, 46 Cleveland Street, London W1P
6DB, United Kingdom. Phone: 44-020 7679 9354. Fax: 44-020 7679 9357. E-mail: J.deSouza{at}ucl.ac.uk.
Editor:
W. A. Petri Jr.
 |
REFERENCES |
| 1.
|
Aikawa, M.,
M. Iseki,
J. W. Barnwell,
D. Taylor,
M. M. Oo, and R. J. Howard.
1990.
The pathology of human cerebral malaria.
Am. J. Trop. Med. Hyg.
43:30-37.
|
| 2.
|
Berendt, A. R.,
G. D. H. Turner, and C. I. Newbold.
1994.
Cerebral malaria: the sequestration hypothesis.
Parasitol. Today
10:412-414[CrossRef][Medline].
|
| 3.
|
Brown, H.,
G. Turner,
S. Rogerson,
M. Tembo,
J. Mwenechanya,
M. Molyneux, and T. Taylor.
1999.
Cytokine expression in the brain in human cerebral malaria.
J. Infect. Dis.
180:1742-1746[CrossRef][Medline].
|
| 4.
|
Burgner, D.,
W. Xu,
K. Rockett,
M. Gravenor,
I. G. Charles,
A. V. Hill, and D. Kwiatkowski.
1998.
Inducible nitric oxide synthase polymorphism and fatal cerebral malaria.
Lancet
352:1193-1194[CrossRef][Medline].
|
| 5.
|
Chan-Ling, T.,
A. L. Neill, and N. H. Hunt.
1992.
Early microvascular changes in murine cerebral malaria detected in retinal wholemounts.
Am. J. Pathol.
140:1121-1130[Abstract].
|
| 6.
|
Clark, I. A., and W. B. Cowden.
1999.
Why is the pathology of falciparum worse than that of vivax malaria?
Parasitol. Today
15:458-461[CrossRef][Medline].
|
| 7.
|
Clark, I. A., and K. Rockett.
1994.
The cytokine theory of human cerebral malaria.
Parasitol. Today
10:410-412[CrossRef][Medline].
|
| 8.
|
Deininger, M. H.,
P. G. Kremsner,
R. Meyermann, and H. J. Schluesener.
2000.
Focal accumulation of cyclooxygenase-1 (COX-1) and COX-2 expressing cells in cerebral malaria.
J. Neuroimmunol.
106:198-205[CrossRef][Medline].
|
| 9.
|
De Kossodo, S., and G. E. Grau.
1993.
Profiles of cytokine production in relation with susceptibility to cerebral malaria.
J. Immunol.
151:4811-4820[Abstract].
|
| 10.
|
de Souza, J. B.,
I. T. Ling,
S. Ogun,
A. A. Holder, and J. H. L. Playfair.
1996.
Cytokines and antibody subclass associated with protective immunity against blood-stage malaria in mice vaccinated with the C terminus of MSP-1 plus a novel adjuvant.
Infect. Immun.
64:3532-3536[Abstract].
|
| 11.
|
de Souza, J. B., and J. H. L. Playfair.
1995.
A novel adjuvant for use with a blood-stage malaria vaccine.
Vaccine
13:1316-1319[CrossRef][Medline].
|
| 12.
|
de Souza, J. B.,
K. E. Williamson,
T. Otani, and J. H. L. Playfair.
1997.
Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.
Infect. Immun.
65:1593-1598[Abstract].
|
| 13.
|
Fernandez, V.,
C. J. Treutiger,
G. B. Nash, and M. Wahlgren.
1998.
Multiple adhesive phenotypes linked to rosetting binding of erythrocytes in Plasmodium falciparum malaria.
Infect. Immun.
66:2969-2975[Abstract/Free Full Text].
|
| 14.
|
Grau, G. E.,
G. Bieler,
P. Pointaire,
S. De Kossodo,
F. Tacchini-Cotier,
P. Vassalli,
P. F. Piguet, and P.-H. Lambert.
1990.
Significance of cytokine production and adhesion molecules in malarial immunopathology.
Immunol. Lett.
25:189-194[CrossRef][Medline].
|
| 15.
|
Grau, G. E.,
L. F. Fajardo,
P. F. Piguet,
B. Allet,
P.-H. Lambert, and P. Vassalli.
1987.
Tumor necrosis factor (cachectin) as an essential mediator in murine cerebral malaria.
Science
237:1210-1212[Abstract/Free Full Text].
|
| 16.
|
Grau, G. E.,
F. Tacchini-Cottier,
C. Vesin,
G. Milon,
J. Lou,
P. F. Piguet, and P. Juillard.
1993.
TNF-induced microvascular pathology: active role for platelets and importance of the LFA-1/ICAM-1 interaction.
Eur. Cytokine Netw.
4:415-419[Medline].
|
| 17.
|
Hviid, L.,
T. G. Theander,
I. M. Elhassan, and J. B. Jensen.
1993.
Increased plasma levels of soluble ICAM-1 and ELAM-1 (E-selectin) during acute Plasmodium falciparum malaria.
Immunol. Lett.
36:51-58[CrossRef][Medline].
|
| 18.
|
Jennings, V. M.,
J. K. Actor,
A. A. Lal, and R. L. Hunter.
1997.
Cytokine profile suggesting that murine cerebral malaria is an encephalitis.
Infect. Immun.
65:4883-4887[Abstract].
|
| 19.
|
Kaul, D.,
X. D. Liu,
R. L. Nagel, and H. L. Shear.
1998.
Microvascular hemodynamics and in vivo evidence for the role of intercellular adhesion molecule-1 in the sequestration of infected red blood cells in a mouse model of lethal malaria.
Am. J. Trop. Med. Hyg.
58:240-247[Abstract].
|
| 20.
|
Kaul, D. K.,
R. L. Nagel,
J. F. Llena, and H. L. Shear.
1994.
Cerebral malaria in mice: demonstration of cytoadherence of infected red blood cells and microrheologic correlates.
Am. J. Trop. Med. Hyg.
50:512-521.
|
| 21.
|
Kawai, S.,
M. Aikawa,
S. Kano, and M. Suzuki.
1993.
A primate model for severe human malaria with cerebral involvement: Plasmodium coatneyi-infected Macaca fuscata.
Am. J. Trop. Med. Hyg.
48:630-636.
|
| 22.
|
Kurtzhals, J. A.,
V. Adabayeri,
B. Q. Goka,
B. D. Akanmori,
J. O. Oliver-Commey,
F. K. Nkrumah,
C. Behr, and L. Hviid.
1998.
Low plasma concentrations of interleukin 10 in severe malarial anaemia compared with cerebral and uncomplicated malaria.
Lancet
351:1768-1772[CrossRef][Medline].
|
| 23.
|
Lou, J.,
Y. R. A. Donati,
P. Juillard,
C. Giroud,
C. Vesin,
N. Mili, and G. E. Grau.
1997.
Platelets play an important role in TNF-induced microvascular endothelial cell pathology.
Am. J. Pathol.
151:1397-1405[Abstract].
|
| 24.
|
MacPherson, G. G.,
M. J. Warrell,
N. J. White,
S. Looareesuwan, and D. A. Warrell.
1985.
Human cerebral malaria: a quantitative ultrastructural analysis of parasitized erythrocyte sequestration.
Am. J. Pathol.
119:385-401[Abstract].
|
| 25.
|
Monsohinard, C.,
J. N. Lou,
C. Behr,
P. Juillard, and G. E. Grau.
1997.
Expression of major histocompatibility complex antigens on mouse brain microvascular endothelial cells in relation to susceptibility to cerebral malaria.
Immunology
92:53-59[CrossRef][Medline].
|
| 26.
|
Muntendam, A. H.,
S. Jaffar,
N. Bleichrodt, and M. B. van Hensbroek.
1996.
Absence of neuropsychological sequelae following cerebral malaria in Gambian children.
Trans. R. Soc. Trop. Med. Hyg.
90:391-394[CrossRef][Medline].
|
| 27.
|
Neill, A. L., and N. H. Hunt.
1992.
Pathology of fatal and resolving Plasmodium berghei cerebral malaria in mice.
Parasitology
105:165-175.
|
| 28.
|
Newbold, C.,
P. Warn,
G. Black,
A. Berendt,
A. Craig,
B. Snow,
M. Msobo,
N. Peshu, and K. Marsh.
1997.
Receptor-specific adhesion and clinical disease in Plasmodium falciparum.
Am. J. Trop. Med. Hyg.
57:389-398.
|
| 29.
|
Pasloske, B. L., and R. J. Howard.
1994.
Malaria, the red cell, and the endothelium.
Annu. Rev. Med.
5:283-295[CrossRef].
|
| 30.
|
Patnaik, J. K.,
B. S. Das,
S. K. Mishra,
S. Mohanty,
S. K. Satpathy, and D. Mohanty.
1994.
Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria.
Am. J. Trop. Med. Hyg.
51:642-647.
|
| 31.
|
Rest, J.
1982.
Cerebral malaria in inbred mice. I. A new model and its pathology.
Trans. R. Soc. Trop. Med. Hyg.
76:410-415[CrossRef][Medline].
|
| 32.
|
Rowe, A.,
J. Obeiro,
C. I. Newbold, and K. Marsh.
1995.
Plasmodium falciparum rosetting is associated with malaria severity in Kenya.
Infect. Immun.
63:2323-2326[Abstract].
|
| 33.
|
Turner, G. D.,
H. Morrison,
M. Jones,
T. M. Davis,
S. Looareesuwan,
I. D. Buley,
K. C. Gatter,
C. I. Newbold,
S. Pukritayakamee, and B. Nagachinta.
1994.
An immunohistochemical study of the pathology of fatal malaria: evidence for widespread endothelial activation and a potential role for intercellular adhesion molecule-1 in cerebral sequestration.
Am. J. Pathol.
145:1057-1069[Abstract].
|
Infection and Immunity, September 2000, p. 5364-5376, Vol. 68, No. 9
0019-9567/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Steeg, C., Adler, G., Sparwasser, T., Fleischer, B., Jacobs, T.
(2009). Limited Role of CD4+Foxp3+ Regulatory T Cells in the Control of Experimental Cerebral Malaria. J. Immunol.
183: 7014-7022
[Abstract]
[Full Text]
-
Cserti, C. M., Dzik, W. H.
(2007). The ABO blood group system and Plasmodium falciparum malaria. Blood
110: 2250-2258
[Abstract]
[Full Text]
-
Lepenies, B., Pfeffer, K., Hurchla, M. A., Murphy, T. L., Murphy, K. M., Oetzel, J., Fleischer, B., Jacobs, T.
(2007). Ligation of B and T Lymphocyte Attenuator Prevents the Genesis of Experimental Cerebral Malaria. J. Immunol.
179: 4093-4100
[Abstract]
[Full Text]
-
Vigario, A. M., Belnoue, E., Gruner, A. C., Mauduit, M., Kayibanda, M., Deschemin, J.-C., Marussig, M., Snounou, G., Mazier, D., Gresser, I., Renia, L.
(2007). Recombinant Human IFN-{alpha} Inhibits Cerebral Malaria and Reduces Parasite Burden in Mice. J. Immunol.
178: 6416-6425
[Abstract]
[Full Text]
-
Nie, C. Q., Bernard, N. J., Schofield, L., Hansen, D. S.
(2007). CD4+ CD25+ Regulatory T Cells Suppress CD4+ T-Cell Function and Inhibit the Development of Plasmodium berghei-Specific TH1 Responses Involved in Cerebral Malaria Pathogenesis. Infect. Immun.
75: 2275-2282
[Abstract]
[Full Text]
-
Hansen, D. S., Bernard, N. J., Nie, C. Q., Schofield, L.
(2007). NK Cells Stimulate Recruitment of CXCR3+ T Cells to the Brain during Plasmodium berghei-Mediated Cerebral Malaria. J. Immunol.
178: 5779-5788
[Abstract]
[Full Text]
-
Gramaglia, I., Sahlin, H., Nolan, J. P., Frangos, J. A., Intaglietta, M., van der Heyde, H. C.
(2005). Cell- Rather Than Antibody-Mediated Immunity Leads to the Development of Profound Thrombocytopenia during Experimental Plasmodium berghei Malaria. J. Immunol.
175: 7699-7707
[Abstract]
[Full Text]
-
Penet, M.-F., Viola, A., Confort-Gouny, S., Le Fur, Y., Duhamel, G., Kober, F., Ibarrola, D., Izquierdo, M., Coltel, N., Gharib, B., Grau, G. E., Cozzone, P. J.
(2005). Imaging Experimental Cerebral Malaria In Vivo: Significant Role of Ischemic Brain Edema. J. Neurosci.
25: 7352-7358
[Abstract]
[Full Text]
-
Franke-Fayard, B., Janse, C. J., Cunha-Rodrigues, M., Ramesar, J., Buscher, P., Que, I., Lowik, C., Voshol, P. J., den Boer, M. A. M., van Duinen, S. G., Febbraio, M., Mota, M. M., Waters, A. P.
(2005). From The Cover: Murine malaria parasite sequestration: CD36 is the major receptor, but cerebral pathology is unlinked to sequestration. Proc. Natl. Acad. Sci. USA
102: 11468-11473
[Abstract]
[Full Text]
-
Voza, T., Vigario, A. M., Belnoue, E., Gruner, A. C., Deschemin, J.-C., Kayibanda, M., Delmas, F., Janse, C. J., Franke-Fayard, B., Waters, A. P., Landau, I., Snounou, G., Renia, L.
(2005). Species-Specific Inhibition of Cerebral Malaria in Mice Coinfected with Plasmodium spp.. Infect. Immun.
73: 4777-4786
[Abstract]
[Full Text]
-
Combes, V., Rosenkranz, A. R., Redard, M., Pizzolato, G., Lepidi, H., Vestweber, D., Mayadas, T. N., Grau, G. E.
(2004). Pathogenic Role of P-Selectin in Experimental Cerebral Malaria: Importance of the Endothelial Compartment. Am. J. Pathol.
164: 781-786
[Abstract]
[Full Text]
-
Sun, G., Chang, W.-L., Li, J., Berney, S. M., Kimpel, D., van der Heyde, H. C.
(2003). Inhibition of Platelet Adherence to Brain Microvasculature Protects against Severe Plasmodium berghei Malaria. Infect. Immun.
71: 6553-6561
[Abstract]
[Full Text]
-
OZWARA, H., LANGERMANS, J. A. M., MAAMUN, J., FARAH, I. O., YOLE, D. S., MWENDA, J. M., WEILER, H., THOMAS, A. W.
(2003). EXPERIMENTAL INFECTION OF THE OLIVE BABOON (PAPIO ANUBIS) WITH PLASMODIUM KNOWLESI: SEVERE DISEASE ACCOMPANIED BY CEREBRAL INVOLVEMENT. Am J Trop Med Hyg
69: 188-194
[Abstract]
[Full Text]
-
Belnoue, E., Costa, F. T. M., Vigario, A. M., Voza, T., Gonnet, F., Landau, I., van Rooijen, N., Mack, M., Kuziel, W. A., Renia, L.
(2003). Chemokine Receptor CCR2 Is Not Essential for the Development of Experimental Cerebral Malaria. Infect. Immun.
71: 3648-3651
[Abstract]
[Full Text]
-
Belnoue, E., Kayibanda, M., Deschemin, J.-C., Viguier, M., Mack, M., Kuziel, W. A., Renia, L.
(2003). CCR5 deficiency decreases susceptibility to experimental cerebral malaria. Blood
101: 4253-4259
[Abstract]
[Full Text]
-
Hanum P., S., Hayano, M., Kojima, S.
(2003). Cytokine and chemokine responses in a cerebral malaria-susceptible or -resistant strain of mice to Plasmodium berghei ANKA infection: early chemokine expression in the brain. Int Immunol
15: 633-640
[Abstract]
[Full Text]
-
Chang, W.-L., Li, J., Sun, G., Chen, H.-L., Specian, R. D., Berney, S. M., Granger, D. N., van der Heyde, H. C.
(2003). P-Selectin Contributes to Severe Experimental Malaria but Is Not Required for Leukocyte Adhesion to Brain Microvasculature. Infect. Immun.
71: 1911-1918
[Abstract]
[Full Text]
-
Belnoue, E., Kayibanda, M., Vigario, A. M., Deschemin, J.-C., Rooijen, N. v., Viguier, M., Snounou, G., Renia, L.
(2002). On the Pathogenic Role of Brain-Sequestered {alpha}{beta} CD8+ T Cells in Experimental Cerebral Malaria. J. Immunol.
169: 6369-6375
[Abstract]
[Full Text]
-
de Souza, J. B., Todd, J., Krishegowda, G., Gowda, D. C., Kwiatkowski, D., Riley, E. M.
(2002). Prevalence and Boosting of Antibodies to Plasmodium falciparum Glycosylphosphatidylinositols and Evaluation of Their Association with Protection from Mild and Severe Clinical Malaria. Infect. Immun.
70: 5045-5051
[Abstract]
[Full Text]
-
Engwerda, C. R., Mynott, T. L., Sawhney, S., De Souza, J. B., Bickle, Q. D., Kaye, P. M.
(2002). Locally Up-regulated Lymphotoxin {alpha}, Not Systemic Tumor Necrosis Factor {alpha}, Is the Principle Mediator of Murine Cerebral Malaria. JEM
195: 1371-1377
[Abstract]
[Full Text]
-
Bagot, S., Idrissa Boubou, M., Campino, S., Behrschmidt, C., Gorgette, O., Guenet, J.-L., Penha-Goncalves, C., Mazier, D., Pied, S., Cazenave, P.-A.
(2002). Susceptibility to Experimental Cerebral Malaria Induced by Plasmodium berghei ANKA in Inbred Mouse Strains Recently Derived from Wild Stock. Infect. Immun.
70: 2049-2056
[Abstract]
[Full Text]
-
Chang, W.-L., Jones, S. P., Lefer, D. J., Welbourne, T., Sun, G., Yin, L., Suzuki, H., Huang, J., Granger, D. N., van der Heyde, H. C.
(2001). CD8+-T-Cell Depletion Ameliorates Circulatory Shock in Plasmodium berghei-Infected Mice. Infect. Immun.
69: 7341-7348
[Abstract]
[Full Text]
-
Lou, J., Lucas, R., Grau, G. E.
(2001). Pathogenesis of Cerebral Malaria: Recent Experimental Data and Possible Applications for Humans. Clin. Microbiol. Rev.
14: 810-820
[Abstract]
[Full Text]
-
Piguet, P. F., Da Kan, C., Vesin, C., Rochat, A., Donati, Y., Barazzone, C.
(2001). Role of CD40-CD40L in Mouse Severe Malaria. Am. J. Pathol.
159: 733-742
[Abstract]
[Full Text]